Research Article
Prescription Practice for Diabetes Management among a Female Population in Primary Health Care
Table 2
Distribution of prescriptions for diabetes and cardiovascular management among the total study population.
| Drug group according to clinical problem | Drug name | Value (%) (regardless of combination status) | Value (%) monotherapy |
| Drugs for hyperglycemia | Metformin | 139 (86.9) | 55 (39.6) | Sulphonylurea | 77 (48.1) | 6 (7.8) | Pioglitazone | 23 (14.4) | 0 | Insulin | 23 (14.4) | 9 (39.1) | Others (acarbose, sitaglibtin) | 5 (3.1) | 0 | Total prescriptions | 267 | 70 |
| Antihypertensive drugs | ACE inhibitors and ARBs | 61 (38.1) | 38 (23.8) | Diuretics (thiazide + indapamide) | 26 (16.2) | 5 (3.1) | B-blocker | 21 (13.1) | 7 (33.3) | Calcium channel blocker | 8 (5) | 1 (12.5) | Total prescriptions | 124 | 49 |
| Lipid lowering agents | Statin | 66 (41.3) | 64 | Others (fibrate, ezetimibe) | 2 | 0 | Total prescription | 68 | 64 |
| Antiplatelets therapy | Aspirin | 38 (23.8) | 35 | clopidogrel | 3 | 0 | Total prescriptions | 41 | 35 |
|
|